Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial

por Cordero De Los Santos, Lina, Feris-Iglesias, Jesús, Aloysia D'Cor, Naveena, Midde, Venkata Jayanth, Patnaik, Badri Narayan, Thollot, Yaël, Rasuli, Anvar, Desauziers, Eric
Publicado 2018

Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India

por Raghava Mohan, Venkata, Raj, Santosh, Dhingra, Mandeep Singh, Aloysia D’Cor, Naveena, Singh, Ajit Pal, Saluja, Tarun, Kim, Deok Ryun, Midde, Venkat Jayanth, Kim, Yanghee, Vemula, Sridhar, Narla, Santhosh Kumar, Sah, Binod, Ali, Mohammad
Publicado 2019

Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants–A randomized study

por Aloysia D’Cor, Naveena, Siddaiah, Prashanth, Mohapatra, Satyajit, Dhaded, Sangappa Malappa, I. V., Padmavathi, Kar, Sonali, V. N., Tripathi, Muley, Prasad, Chhatwal, Jugesh, Patnaik, Badri Narayan, Vidor, Emmanuel, Moureau, Annick, Patel, Dhaval M., Midde, Venkata Jayanth, Jagga, Sathish Reddy, Peesapati, Satyanarayana, Noriega, Fernando
Publicado 2023